ImageneBio Change In Cash from 2010 to 2026
| IMA Stock | 6.91 0.10 1.43% |
Change In Cash | First Reported 2019-12-31 | Previous Quarter 21.5 M | Current Value 44.9 M | Quarterly Volatility 56.6 M |
Check ImageneBio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among ImageneBio's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.8 M, Selling General Administrative of 14.6 M or Total Revenue of 3.8 M, as well as many indicators such as Price To Sales Ratio of 296, Dividend Yield of 0.0 or PTB Ratio of 7.13. ImageneBio financial statements analysis is a perfect complement when working with ImageneBio Valuation or Volatility modules.
ImageneBio | Change In Cash | Build AI portfolio with ImageneBio Stock |
Analyzing ImageneBio's Change In Cash over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Change In Cash has evolved provides context for assessing ImageneBio's current valuation and future prospects.
Latest ImageneBio's Change In Cash Growth Pattern
Below is the plot of the Change In Cash of ImageneBio over the last few years. It is ImageneBio's Change In Cash historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in ImageneBio's overall financial position and show how it may be relating to other accounts over time.
| Change In Cash | 10 Years Trend |
|
Change In Cash |
| Timeline |
ImageneBio Change In Cash Regression Statistics
| Arithmetic Mean | (7,414,105) | |
| Coefficient Of Variation | (856.64) | |
| Mean Deviation | 43,004,749 | |
| Median | (639,000) | |
| Standard Deviation | 63,512,313 | |
| Sample Variance | 4033.8T | |
| Range | 253.6M | |
| R-Value | (0.29) | |
| Mean Square Error | 3945.2T | |
| R-Squared | 0.08 | |
| Significance | 0.26 | |
| Slope | (3,625,510) | |
| Total Sum of Squares | 64541T |
ImageneBio Change In Cash History
About ImageneBio Financial Statements
ImageneBio stakeholders use historical fundamental indicators, such as ImageneBio's Change In Cash, to determine how well the company is positioned to perform in the future. Although ImageneBio investors may analyze each financial statement separately, they are all interrelated. For example, changes in ImageneBio's assets and liabilities are reflected in the revenues and expenses on ImageneBio's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in ImageneBio. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Change In Cash | -72.8 M | -69.2 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether ImageneBio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of ImageneBio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Imagenebio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Imagenebio Stock:Check out the analysis of ImageneBio Correlation against competitors. For information on how to trade ImageneBio Stock refer to our How to Trade ImageneBio Stock guide.You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ImageneBio. Market participants price ImageneBio higher when confident in its future expansion prospects. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive ImageneBio assessment requires weighing all these inputs, though not all factors influence outcomes equally.
ImageneBio's market price often diverges from its book value, the accounting figure shown on ImageneBio's balance sheet. Smart investors calculate ImageneBio's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Since ImageneBio's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between ImageneBio's value and its price as these two are different measures arrived at by different means. Investors typically determine if ImageneBio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ImageneBio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.